Cargando…

COVID-19 myocardial injury: We have much more to discover

Detalles Bibliográficos
Autores principales:	Vrachatis, Dimitrios A., Giotaki, Sotiria G., Giannopoulos, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295704/ https://www.ncbi.nlm.nih.gov/pubmed/32560766 http://dx.doi.org/10.1016/j.ijcard.2020.05.003

Ejemplares similares

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis
por: Sanz-Sánchez, Jorge, et al.
Publicado: (2021)

Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021)

The more we know, the more we have to discover: an exciting future for understanding cilia and ciliopathies
por: Benmerah, Alexandre, et al.
Publicado: (2015)

Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2021)

Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021)

Choroidal thickness in patients with systemic arterial hypertension: a systematic review and meta-analysis
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2022)

Efficacy, Safety and Feasibility of Superior Vena Cava Isolation in Patients Undergoing Atrial Fibrillation Catheter Ablation: An Up-to-Date Review
por: Vrachatis, Dimitrios A., et al.
Publicado: (2023)

Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis
por: Vrachatis, Dimitrios A., et al.
Publicado: (2022)

Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021)

Left atrial appendage morphofunctional indices could be predictive of arrhythmia recurrence post-atrial fibrillation ablation: a meta-analysis
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2023)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)

DISCOVER: much accomplished, but not yet for all
por: Spiegel, Hans M L
Publicado: (2020)

Dermatology and COVID-19: Much knowledge to date but still a lot to discover
por: Le Cleach, L.
Publicado: (2021)

The mask (which we need so much is the one we would have needed)()()
por: Torres, L.M., et al.
Publicado: (2020)

How much will the vaccine cost (if ever discovered….)
por: Marengo, Luigi
Publicado: (2020)

Constipation in critically ill patients: much more than we imagine
por: de Azevedo, Rodrigo Palácio, et al.
Publicado: (2013)

What Can We Learn from “Not Much More than g”?
por: Murphy, Kevin
Publicado: (2017)

Less is More: We are Administering Too Much Protamine in Cardiac Surgery
por: De Simone, Francesco, et al.
Publicado: (2021)

How Much Progress Have We Made? Trends in Disparities in Tobacco Use
por: Kingsbury, J.H., et al.
Publicado: (2020)

Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis
por: Anagnostopoulos, Ioannis, et al.
Publicado: (2023)

The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
por: Deftereos, Spyridon G., et al.
Publicado: (2020)

Milan 2020: COVID-19, neuro-oncology and much more
por: Finocchiaro, Gaetano
Publicado: (2020)

Real World Evidence: Can We Really Expect It to Have Much Influence?
por: Evans, Keith
Publicado: (2019)

Expression of Genes Involved in Axon Guidance: How Much Have We Learned?
por: Kim, Sung Wook, et al.
Publicado: (2020)

Editorial: Open Abdominal Treatment: How Much Evidence Do We Have?
por: Willms, Arnulf Gregor, et al.
Publicado: (2021)

New Strategies for the Reduction of Uremic Toxins: How Much More We Know
por: Rocchetti, Maria Teresa
Publicado: (2021)

What are we learning about supersymmetry from not having discovered it yet?
por: Pokorski, Stefan, et al.
Publicado: (1998)

Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins
por: Nishibori, Masahiro, et al.
Publicado: (2021)

An Updated View on the Rck Invasin of Salmonella: Still Much to Discover
por: Mambu, Julien, et al.
Publicado: (2017)

How to have a brilliant life: put a little more in get so much more out
por: Heppell, Michael
Publicado: (2012)

We are operating too much
por: Maffulli, Nicola
Publicado: (2017)

We Eat Too Much
Publicado: (1890)

Supersymmetry measurements with ATLAS: After we have discovered New Physics, can we understand what it is?
por: Lari, T
Publicado: (2008)

Myocardial Injuries in COVID-19: More Questions Than Answers
por: Bardaji, Alfredo
Publicado: (2022)

Comparative genomics of archaea: how much have we learned in six years, and what's next?
por: Makarova, Kira S, et al.
Publicado: (2003)

Recovery in water polo: how much do we have to know? A systematic review
por: Barrenetxea-Garcia, Josu, et al.
Publicado: (2022)

Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
por: Rabbani, Naila, et al.
Publicado: (2020)

Genetic Screening for Growth Hormone Therapy in Children Small for Gestational Age: So Much to Consider, Still Much to Discover
por: Giacomozzi, Claudio
Publicado: (2021)

Medical Decision and Patient's Preference: 'Much Ethics' and More Trust Always Needed
por: Anyfantakis, Dimitrios, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uqg8o8mkmckf22c08oho7at0cb